Ptc Therapeutics (PTCT) Payables (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Payables of $382.2 million for Q2 2026, up 12.77% year-over-year from $338.9 million in Q2 2025, and up 22.1% quarter-over-quarter from $313.0 million in Q1 2026.
Ptc Therapeutics (PTCT) Payables (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Payables history runs 15 years deep, the most recent figure standing at $382.2 million for Q2 2026.
- In Q2 2026, Payables rose 12.77% year-over-year to $382.2 million; the TTM figure through Jun 2026 stood at $382.2 million (up 12.77% YoY), while the FY2025 annual figure was $381.3 million, up 25.3% from the prior year.
- Payables for Q2 2026 stood at $382.2 million, up from $313.0 million in the prior quarter.
- The five-year high for Payables was $392.0 million in Q4 2023, with the low at $246.5 million in Q1 2022.
- The 5-year median for Payables is $331.5 million (2023), against an average of $334.9 million.
- The sharpest annual moves came in 2022 and 2024: Payables surged 40.27% in 2022, then declined 22.37% in 2024.
- Ptc Therapeutics' Payables stood at $320.4 million in 2022, then climbed by 22.35% to $392.0 million in 2023, then declined by 22.37% to $304.3 million in 2024, then gained by 25.3% to $381.3 million in 2025, then increased by 0.26% to $382.2 million in 2026.
- Business Quant data shows PTCT's Payables at $382.2 million in Q2 2026, $313.0 million in Q1 2026, and $381.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 382.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 382.25 Mn |
| Mar 31, 2026 | 313.05 Mn |
| Dec 31, 2025 | 381.27 Mn |
| Sep 30, 2025 | 303.14 Mn |
| Jun 30, 2025 | 338.95 Mn |
| Mar 31, 2025 | 15.15 Mn |
| Dec 31, 2024 | 17.27 Mn |
| Sep 30, 2024 | 336.35 Mn |
| Jun 30, 2024 | 338.80 Mn |
| Mar 31, 2024 | 27.46 Mn |
| Dec 31, 2023 | 391.98 Mn |
| Sep 30, 2023 | 370.73 Mn |
| Jun 30, 2023 | 358.56 Mn |
| Mar 31, 2023 | 26.31 Mn |
| Dec 31, 2022 | 320.37 Mn |
| Sep 30, 2022 | 329.32 Mn |
| Jun 30, 2022 | 22.88 Mn |
| Mar 31, 2022 | 246.52 Mn |
| Dec 31, 2021 | 288.78 Mn |
| Sep 30, 2021 | 252.33 Mn |